高级检索
当前位置: 首页 > 详情页

MicroRNA-188-5p targeting Forkhead Box L1 promotes colorectal cancer progression via activating Wnt/beta-catenin signaling

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 预警期刊

机构: [1]Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Hepatobiliary & Pancreat Surg, Union Shenzhen Hosp, Shenzhen, Peoples R China [3]Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Gastrointestinal Surg, Guangzhou, Peoples R China [4]Guangdong Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
出处:
ISSN:

关键词: CELL-PROLIFERATION TUMOR-SUPPRESSOR DOWN-REGULATION GASTRIC-CANCER BETA-CATENIN PROSTATE-CANCER BREAST-CANCER FOXL1 METASTASIS EXPRESSION

摘要:
Objective: MicroRNA-188-5p (miR-188) enhances oncologic progression in various human malignancies. This study aimed to explore its role in colorectal cancer (CRC). Materials and Methods: Human CRC tissues paired with normal tissues, and several CRC cell lines were utilized. Real-time quantitative PCR was applied to measure the expression of miR-188. Overexpression and knockdown were used to access the function of miR-188 and to investigate whether FOXL1/Wnt signaling mediates such function. The proliferation, migration and invasion of cancer cells were evaluated by CCK8, wound-healing and transwell assays, respectively. Whether FOXL1 acted as a direct target of miR-188 was verified by dual-luciferase reporter assays. Results: Levels of miR-188 were upregulated in CRC tissues than in paired-normal tissues, as well as in various CRC cell lines. High expression of miR-188 was strongly associated with advanced tumor stage, accompanied with significant tumor cell proliferation, invasion and migration. It was confirmed that FOXL1 played positive crosstalk between miR-188 regulation and downstream Wnt/beta-catenin signaling activation. Conclusions: All findings indicate that miR-188 promotes CRC cell proliferation and invasion through targeting FOXL1/Wnt signaling and could be served as a potential therapeutic target for human CRC in the future.

基金:

基金编号: 201904010036 2017YFC1308800 81871908 2018A030313715 2017YFC1308803

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q2 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Hepatobiliary & Pancreat Surg, Union Shenzhen Hosp, Shenzhen, Peoples R China
通讯作者:
通讯机构: [1]Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Peoples R China [*1]Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Peoples R China [*2]Guangdong Gen Hosp, Dept Hematol, Guangzhou, Peoples R China [4]Guangdong Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23405 今日访问量:0 总访问量:1276 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)